Smith & Nephew plc (LON:SN) had its price target boosted by research analysts at J P Morgan Chase & Co from GBX 1,361 ($18.08) to GBX 1,382 ($18.36) in a research note issued on Thursday. The firm currently has a “neutral” rating on the stock. J P Morgan Chase & Co’s price objective would suggest a potential downside of 2.74% from the stock’s current price.

SN has been the topic of several other reports. Citigroup Inc. reissued a “sell” rating and issued a GBX 1,160 ($15.41) target price on shares of Smith & Nephew plc in a research report on Thursday, June 22nd. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and issued a GBX 1,380 ($18.34) target price on shares of Smith & Nephew plc in a research report on Friday, June 30th. HSBC Holdings plc reissued a “hold” rating and issued a GBX 1,320 ($17.54) target price on shares of Smith & Nephew plc in a research report on Monday, July 10th. Deutsche Bank AG reissued a “hold” rating and issued a GBX 1,200 ($15.94) target price on shares of Smith & Nephew plc in a research report on Monday, July 17th. Finally, Berenberg Bank reissued a “hold” rating and issued a GBX 1,300 ($17.27) target price on shares of Smith & Nephew plc in a research report on Tuesday, July 18th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of GBX 1,291 ($17.15).

Shares of Smith & Nephew plc (SN) opened at 1423.00 on Thursday. Smith & Nephew plc has a 52-week low of GBX 1,064.91 and a 52-week high of GBX 1,432.54. The stock has a 50 day moving average of GBX 1,371.68 and a 200 day moving average of GBX 1,333.80. The firm’s market capitalization is GBX 12.46 billion.

ILLEGAL ACTIVITY WARNING: “Smith & Nephew plc (SN) PT Raised to GBX 1,382 at J P Morgan Chase & Co” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/19/smith-nephew-plc-sn-pt-raised-to-gbx-1382-at-j-p-morgan-chase-co.html.

In related news, insider Virginia Bottomley acquired 223 shares of the stock in a transaction that occurred on Wednesday, August 16th. The shares were purchased at an average cost of GBX 1,380 ($18.34) per share, with a total value of £3,077.40 ($4,089.02).

About Smith & Nephew plc

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Analyst Recommendations for Smith & Nephew plc (LON:SN)

Receive News & Stock Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related stocks with our FREE daily email newsletter.